Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

Serum calprotectin is not a reliable marker for alopecia areata activity.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Fetal skin has unique immune cells different from adult skin.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Blood and urine markers are important for diagnosing lupus in children.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Mice with autoimmune hair loss showed signs of heart problems.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Different types of male pattern baldness have unique inflammation-related protein patterns.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Alopecia areata patients have higher IFN-γ and low vitamin D3 levels.

Autoimmune gastritis is a common cause of iron deficiency and should be included in diagnostic guidelines.

Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Anti-keratin antibody from cow milk makes damaged hair stronger and less likely to break.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Certain gene variations may increase the risk and severity of alopecia areata.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.